Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes.
- Author:
Jong Hyeon PARK
1
;
Sun Jin KIM
;
Jae Ku OEM
;
Kwang Nyeong LEE
;
Yong Joo KIM
;
Soo Jeong KYE
;
Jee Yong PARK
;
Yi Seok JOO
Author Information
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords: foot and mouth disease; immunogenicity; interleukin-1
- MeSH: Animals; Antibodies, Viral/blood; Capsid Proteins/biosynthesis/genetics/*immunology; Cell Line; DNA, Viral/genetics; Enzyme-Linked Immunosorbent Assay; Foot-and-Mouth Disease/*immunology/prevention&control; Foot-and-Mouth Disease Virus/genetics/*immunology; Haplorhini; Immunization; Interleukin-1/biosynthesis/genetics/*immunology; Male; Mice; Mice, Inbred C57BL; Plasmids/genetics; Polymerase Chain Reaction; Recombinant Fusion Proteins/biosynthesis/genetics/immunology; Specific Pathogen-Free Organisms; Transfection; Vaccines, DNA/genetics/*immunology
- From:Journal of Veterinary Science 2006;7(3):257-262
- CountryRepublic of Korea
- Language:English
- Abstract: The capsid of the foot and mouth disease (FMD) virus carries the epitopes that are critical for inducing the immune response. In an attempt to enhance the specific immune response, plasmid DNA was constructed to express VP1/interleukin-1alpha (IL-1alpha) and precursor capsid (P1) in combination with 2A (P1-2A)/IL-1alpha under the control of the human cytomegalovirus (HCMV) immediateearly promoter and intron. After DNA transfection into MA104 (monkey kidney) cells, Western blotting and an immunofluorescence assay were used to confirm the expression of VP1 or P1-2A and IL-1alpha. Mice were inoculated with the encoding plasmids via the intradermal route, and the IgG1 and IgG2a levels were used to determine the immune responses. These results show that although the immunized groups did not carry a high level of neutralizing antibodies, the plasmids encoding the VP1/ IL-1alpha, and P1-2A /IL-1alpha fused genes were effective in inducing an enhanced immune response.
